Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...
After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of& | ...
Proteins often function in pairs or groups, concealing their internal connection points and making it difficult for ...
Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...
AdvanCell and 48Hour Discovery Announce Collaboration and Exclusive Licensing Agreement to Develop a Lead-212 Alpha ...
Rochester, Minn.-based Mayo Clinic and pharmaceutical giant Merck are teaming up to leverage AI for drug discovery and ...
Ten63 Therapeutics, an advanced AI drug-discovery company, today announced that it added strategic investment from new investors Chugai Venture Fund and the Gates Foundation, bringing the Company's ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: A new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...
24/7 Wall St. on MSN
Why Eli Lilly’s $1 billion AI bet could reshape drug discovery
Quick Read Eli Lilly (LLY) reported Q4 EPS of $7.54 versus $6.67 expected. Eli Lilly projected 2026 revenue of $80-83B. Eli ...
Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results